Brimonidine Tartrate and Timolol Maleate NDC 62332-706

NDC codes

FDA NDC Directory

Product NDC (as listed)62332-706Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62332-0706Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62332-706-05	62332070605	1 BOTTLE, DROPPER in 1 CARTON (62332-706-05) / 5 mL in 1 BOTTLE, DROPPERMarketed from Aug 25, 2023
62332-706-10	62332070610	1 BOTTLE, DROPPER in 1 CARTON (62332-706-10) / 10 mL in 1 BOTTLE, DROPPERMarketed from Aug 25, 2023
62332-706-15	62332070615	1 BOTTLE, DROPPER in 1 CARTON (62332-706-15) / 15 mL in 1 BOTTLE, DROPPERMarketed from Aug 25, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Brimonidine Tartrate and Timolol Maleate
Generic name (nonproprietary): brimonidine tartrate and timolol maleate
Active ingredients: Brimonidine tartrate — 2 mg/mLTimolol maleate — 5 mg/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Alembic Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215230
Marketing start: Aug 25, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha-Agonists (Mechanism)Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 62332-706_71456640-f2cd-41a7-920e-88e042028bbbSPL ID 71456640-f2cd-41a7-920e-88e042028bbbSPL set ID 10e79593-b991-4899-89fd-6fff7a213d81RxCUI 861635UNII 4S9CL2DY2H, P8Y54F701R
Pharmacologic class: alpha-Adrenergic Agonist; beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462332070605 followed by a unit qualifier and the quantity

Package 62332-0706-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 1, 2026.

Indications (excerpt from the label)

Brimonidine tartrate and timolol maleate ophthalmic solution 0.2% /0.5% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP. The IOP-lowering of brimonidine tartrate and timolol maleate ophthalmic solution dosed twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol maleate ophthalmic solution dosed twice a day and 0.2% brimonidine tartrate ophthalmic solution dosed three times per day. Brimonidine tartrate and timolol maleate ophthalmic solution is a combination of brimonidine tartrate, an alpha-adrenerg…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 215230

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215230
Product	Strength	Form · route	Labeler	Product NDC
Brimonidine Tartrate and Timolol Maleate	Brimonidine tartrate 2 mg/mL; Timolol maleate 5 mg/mL	Solution/ dropsOphthalmic	Alembic Pharmaceuticals Limited	46708-706